About Index Trending news
Analyze
Pricing
Galena Biopharma

Galena Biopharma

Work at Galena Biopharma? Add yourself to this profile

Galena Biopharma

Galena Biopharma is a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments to advance cancer care.
Edit Profile
More info

Elsewhere

Also headquartered in Portland

Simple Simple Drip Drip Coolest Cooler Coolest Cooler Fios Fios Wieden + Kennedy Wieden + Kennedy Urban Airship Urban Airship Puppet Labs Puppet Labs Skyward Skyward Cloudability Cloudability Elemental Elemental

Companies in the same industry

Alimera Sciences Alimera Sciences KannaLife Sciences KannaLife Sciences Aerie Pharmaceuticals Aerie Pharmaceuticals Cellectis Cellectis molecular assemblies molecular assemblies Hyasynth Bio Hyasynth Bio Chantest Chantest FlowMetric FlowMetric Mitochon Pharmaceuticals Mitochon Pharmaceuticals Arrivo BioVentures LLC Arrivo BioVentures LLC

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 1
Add info
Latest funding
Post-IPO debt
$24,000,000
Employees

Unknown size

Locations
HQ
Portland, United States
Headquarters
The Motley Fool

These 2 Catalysts Helped Push Galena Biopharma, Inc. 31% Higher in May

Galena Biopharma
Galena Biopharma
The Motley Fool

Why Galena Biopharma, Inc. Was on the Fast Track to a Higher Stock Price Today

Galena Biopharma
Galena Biopharma
The Motley Fool

The Single Reason Why Galena Biopharma, Inc. Rallied 67% in March

Health Stock markets
Galena Biopharma
Galena Biopharma
The Motley Fool

Why Galena Biopharma Inc PRESENTed a Higher Stock Price

Galena Biopharma
Galena Biopharma
The Motley Fool

Galena Biopharma Gives Shareholders 3 More Reasons to Bury Their Heads in the Sand --

Galena Biopharma
Galena Biopharma
The Motley Fool

3 Things Galena Biopharma Inc. Wants You to Know --

Health Stock markets Earnings
Galena Biopharma
Galena Biopharma
The Motley Fool

Galena Biopharma's 3rd-Quarter Report Is Nothing Short of Bizarre --

Health Stock markets
Galena Biopharma
Galena Biopharma
The Motley Fool

Here's Why Galena Biopharma's Stock Tanked Today --

Galena Biopharma
Galena Biopharma
The Motley Fool

4 Questions to Ask Ahead of Galena Biopharma's Third-Quarter Earnings Report --

Stock markets Health Earnings
Galena Biopharma
Galena Biopharma